ROGGEN APO
ActiveSummary
ROGGEN APO has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17,071 and a net result of €5,071. Its solvency ranks better than 38% of 13,741 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Official details
Source: KBO- Status
- Active since 21-06-2024 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Establishment unit
- 2.362.065.113 1702 Dilbeek, since 21-06-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 12-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.1%
- Gross margin
- €6,523
- Turnover
- ≈ €64,000
- estimated
- Profit
- €5,071
- Equity
- €17,071
- Total assets
- €68,518
- 2025 accounts filed 30 days after the deadline
Score breakdownraises riskFounded in 2024Size: total assets €68,518Last filed accounts filed 30 days latelowers riskLiquidity: current ratio 1.33, cash €25,307Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 36% of them on solvency, 61% on liquidity and 42% on profitability.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Recent changes
- · Gazette deed IncorporationStarting capital €12,000 · Appointment: DE VLAMYNCK Bart Lieven Jurgen (director)
Comparable companies
These companies have the same main activity as ROGGEN APO: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €56,500 and €103,000, founded between 2021 and 2025.
| Company | Total assets | Gross margin |
|---|---|---|
| ROGGEN APO Dilbeek | €68,518 | €6,523 |
| Smartvalue Distribution Liège | €56,516 | €8,039 |
| QM International Genk | €74,906 | €14,402 |
| Labman Torhout | €102,667 | €3,597 |
| MEDISCHMATERIAAL.BE Stekene | €73,179 | €19,437 |
| MACRIA Antwerpen | €64,637 | €9,781 |
| LIWAES Roosdaal | €98,407 | €14,851 |
Key facts about ROGGEN APO
- What is the company number of ROGGEN APO?
- The company number of ROGGEN APO is 1010.619.244. The VAT number is the same number with BE in front: BE 1010.619.244.
- Where is ROGGEN APO based?
- The registered office is at Brusselstraat 322, 1702 Dilbeek.Company details
- What does ROGGEN APO do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of ROGGEN APO?
- The legal form of ROGGEN APO is Private limited company (BV).
- When was ROGGEN APO founded?
- ROGGEN APO was founded on 21-06-2024.
- Is ROGGEN APO still active?
- Yes, ROGGEN APO is an active enterprise in the KBO register.
- What is the turnover of ROGGEN APO?
- The turnover in financial year 2025 is ≈ €64,000. This figure is estimated from the gross margin of €6,523 and 41 comparable companies (NACE 464). It probably lies between €37,000 and €260,000. It is a rough estimate.Financials
- Is ROGGEN APO profitable?
- In financial year 2025, ROGGEN APO made a profit of €5,071.
- Where can I find the annual accounts of ROGGEN APO?
- ROGGEN APO filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.